U.S. market Closed. Opens in 1 hour 32 minutes

SCPS | Scopus BioPharma Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.0003 - 0.0003
52 Week Range 0.0001 - 0.0637
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 154,700
Average Volume 10,099
Shares Outstanding 42,084,300
Market Cap 12,625
Sector Healthcare
Industry Biotechnology
IPO Date 2020-12-16
Valuation
Profitability
Growth
Health
P/E Ratio N/A
Forward P/E Ratio N/A
EPS -0.31
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 13
Country USA
Website SCPS
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.
SCPS's peers: AKTX, MNPR, PCSA, SCPH, TPST, SQFT
*Chart delayed
Analyzing fundamentals for SCPS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see SCPS Fundamentals page.

Watching at SCPS technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SCPS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙